Compound ID | 3294
Synonym(s): OTB658 | OTB 658
Class: Oxazolidinone
| Details of activity: | Active against Mycobacterium tuberculosis; protein synthesis inhibitor |
| Propensity to select resistant mutants: | Yes, at frequency of 9.09 × 10^-9 to 3.3 × 10^-8 at 4xMIC |
| Description: | Synthetic compound; shows comparable potency as rifampicin in Mycobacterium tuberculosis infected macrophage cells |
| Year first mentioned: | 2020 |
| Highest developmental phase: | Preclinical (approved Phase 1 clinical trial in China) |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/156495313 |
| Guide to Pharmacology: | OTB-658 |
| Citations: |
|